Daily FNArena News - Australia

Another quarter, another failed bid, another earnings downgrade. Billabong is increasingly in the hands of the financiers.

Transpacific downgraded earnings forecasts for FY13, largely because of work deferrals, but brokers are confident the business will cope.

A wrap of the day’s activity on the Australian stock market.

The Aussie is still overvalued, says the RBA, and there’s more scope for further rate cuts.

The RBA has left its cash rate on hold at 2.75%

Cochlear delivered the earnings estimate downgrade that brokers feared. Now that’s out of the way, the outlook is a little more rosy.

Dun & Bradstreet’s latest Australian National Business Expectations Survey shows selling prices are set to lift from 24-year lows and earnings outlooks are improving.

A wrap of the day’s activity on the Australian stock market.

The low AUD is already impacting on the Australian Healthcare sector in terms of positive earnings forecast and target revisions.

Weekly update on recommendation, target price, and earnings forecast changes.